Nonprofit Acquires Abandoned Leukemia Drug Supply. (PubMed, Cancer Discov) - Jul 14, 2026 - "The nonprofit organization Blood Cancer United acquired the remaining supply of luveltamab tazevibulin and will continue the compassionate use program for children with a rare form of AML. The move points to the challenges of funding pediatric cancer drug development."
Journal • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology • Pediatrics
|